ES2067244T3 - Compuestos peptidicos que presentan una actividad de liberacion de la hormona del crecimiento. - Google Patents

Compuestos peptidicos que presentan una actividad de liberacion de la hormona del crecimiento.

Info

Publication number
ES2067244T3
ES2067244T3 ES91915321T ES91915321T ES2067244T3 ES 2067244 T3 ES2067244 T3 ES 2067244T3 ES 91915321 T ES91915321 T ES 91915321T ES 91915321 T ES91915321 T ES 91915321T ES 2067244 T3 ES2067244 T3 ES 2067244T3
Authority
ES
Spain
Prior art keywords
hormone
growth
liberation
activity
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91915321T
Other languages
English (en)
Inventor
Cyril Y Bowers
John C Hubbs
Charles H Foster
Wayne L Cody
Frank A Momany
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polygen Holding Corp
Original Assignee
Polygen Holding Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polygen Holding Corp filed Critical Polygen Holding Corp
Application granted granted Critical
Publication of ES2067244T3 publication Critical patent/ES2067244T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Slide Fasteners, Snap Fasteners, And Hook Fasteners (AREA)
  • Stringed Musical Instruments (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

SE DESCRIBEN POLIPEPTIDOS NUEVOS QUE PROMUEVEN LA LIBERACION DE LA HORMONA DEL CRECIMIENTO CUANDO SE ADMINISTRAN A ANIMALES. ESTOS POLIPEPTIDOS TIENEN LA FORMULA: A1 A3 - TRP - A5 - A6 - Z O AWIQ - DPHE - A3 - TRP - A5 - A6 - Z.
ES91915321T 1990-07-24 1991-07-23 Compuestos peptidicos que presentan una actividad de liberacion de la hormona del crecimiento. Expired - Lifetime ES2067244T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55722690A 1990-07-24 1990-07-24
US55812090A 1990-07-24 1990-07-24

Publications (1)

Publication Number Publication Date
ES2067244T3 true ES2067244T3 (es) 1995-03-16

Family

ID=27071367

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91915321T Expired - Lifetime ES2067244T3 (es) 1990-07-24 1991-07-23 Compuestos peptidicos que presentan una actividad de liberacion de la hormona del crecimiento.

Country Status (26)

Country Link
EP (1) EP0540676B1 (es)
JP (1) JPH05509105A (es)
KR (1) KR927002373A (es)
CN (1) CN1061606A (es)
AT (1) ATE114157T1 (es)
AU (1) AU667186B2 (es)
BG (1) BG97334A (es)
BR (1) BR9106676A (es)
CA (1) CA2086928A1 (es)
CZ (1) CZ401392A3 (es)
DE (1) DE69105207T2 (es)
DK (1) DK0540676T3 (es)
ES (1) ES2067244T3 (es)
FI (1) FI930261A7 (es)
GR (1) GR3014916T3 (es)
HU (2) HUT62605A (es)
IE (1) IE912585A1 (es)
IL (1) IL98910A0 (es)
MX (1) MX9100341A (es)
NO (1) NO930203L (es)
NZ (1) NZ239079A (es)
PL (1) PL167804B1 (es)
PT (1) PT98439A (es)
RO (1) RO111370B1 (es)
SK (1) SK2793A3 (es)
WO (1) WO1992001711A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663146A (en) * 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
WO1994007519A1 (en) * 1992-09-25 1994-04-14 Smithkline Beecham Corporation Growth hormone releasing peptides
UA42747C2 (uk) * 1993-12-23 2001-11-15 Ново Нордіск А/С Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
HU221092B1 (en) * 1993-12-23 2002-08-28 Novo Nordisk As Compounds with growth hormone releasing properties
US20020111461A1 (en) 1999-05-21 2002-08-15 Todd C. Somers Low molecular weight peptidomimetic growth hormone secretagogues
US5798337A (en) * 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
CN1127488C (zh) * 1996-04-24 2003-11-12 诺沃挪第克公司 具有生长激素释放特性的化合物
JP4116097B2 (ja) 1997-06-20 2008-07-09 ノボ ノルディスク アクティーゼルスカブ 成長ホルモン放出特性をもつ化合物
ATE470671T1 (de) 1998-01-16 2010-06-15 Helsinn Therapeutics Us Inc Verbindungen mit wachstumshormon-freisetzender eigenschaft
WO1999039730A1 (en) * 1998-02-09 1999-08-12 Kaken Pharmaceutical Co., Ltd. Oral preparations containing peptides promoting the secretion of growth hormone
US6919315B1 (en) 1998-06-30 2005-07-19 Novo Nordisk A/S Compounds with growth hormone releasing properties
CN100506844C (zh) * 1999-07-23 2009-07-01 寒川贤治 新的肽
UA73530C2 (uk) 1999-11-10 2005-08-15 Ново Нордіск А/С Сполука з властивостями вивільнювати гормон росту
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1175810A (en) * 1979-03-30 1984-10-09 Frank A. Momany Synthetic peptides having pituitary growth hormone releasing activity
US4880778A (en) * 1986-05-12 1989-11-14 Eastman Kodak Company Combinations having synergistic growth hormone releasing activity and methods for use thereof
US4839344A (en) * 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
AU628322B2 (en) * 1988-01-28 1992-09-17 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
WO1989007110A1 (en) * 1988-01-28 1989-08-10 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
WO1989010933A1 (en) * 1988-05-11 1989-11-16 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity

Also Published As

Publication number Publication date
HUT62605A (en) 1993-05-28
PL167804B1 (pl) 1995-11-30
HU9300192D0 (en) 1993-04-28
EP0540676B1 (en) 1994-11-17
IL98910A0 (en) 1992-07-15
CA2086928A1 (en) 1992-01-25
MX9100341A (es) 1992-08-10
CN1061606A (zh) 1992-06-03
AU667186B2 (en) 1996-03-14
FI930261A0 (fi) 1993-01-22
HU210611A9 (en) 1995-05-29
IE912585A1 (en) 1992-01-29
DE69105207D1 (de) 1994-12-22
NO930203D0 (no) 1993-01-21
PT98439A (pt) 1992-05-29
KR927002373A (ko) 1992-09-03
WO1992001711A1 (en) 1992-02-06
SK2793A3 (en) 1993-09-08
PL297850A1 (en) 1993-09-20
NO930203L (no) 1993-01-21
ATE114157T1 (de) 1994-12-15
NZ239079A (en) 1994-01-26
JPH05509105A (ja) 1993-12-16
GR3014916T3 (en) 1995-05-31
EP0540676A1 (en) 1993-05-12
BR9106676A (pt) 1993-06-22
RO111370B1 (ro) 1996-09-30
DK0540676T3 (da) 1995-05-01
CZ401392A3 (en) 1994-02-16
AU8425991A (en) 1992-02-18
FI930261L (fi) 1993-01-22
DE69105207T2 (de) 1995-05-11
FI930261A7 (fi) 1993-01-22
BG97334A (bg) 1994-03-24

Similar Documents

Publication Publication Date Title
DK0605484T3 (da) Peptider med væksthormonfrigørende aktivitet
UY23835A1 (es) Procedimiento para la preparacion de compuesto de acilo
DE3853566D1 (de) Formulierungen von Tetrazyklinverbindungen mit kontrollierter Freisetzung.
DE68915291D1 (de) Verschlusskörpr zur verabreichung einer physiologisch aktiven substanz.
ES2105924B1 (es) Derivados de indol.
LV11985A (lv) Noteiktu cistina atvasinajumu farmakologiska izmantosana
MX9100341A (es) Compuestos de polipeptido que tiene actividad liberadora de hormona de crecimiento
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
DE69718469D1 (de) Verbindungen mit wachtumshormon freisetzenden eigenschaften
ES2052533T3 (es) Composicion farmaceutica que comprende 2',3'-didesoxicitidin-2'-eno (2',3'-dideshidrocitidina) para tratar pacientes infectados con retrovirus.
ES2085898T3 (es) Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina.
DE69213177D1 (de) Verbesserte Fischzucht
SE7704856L (sv) Medel for oral tillforsel pa husdjur utan cellulosasmeltning i vam
ES2193399T3 (es) Derivados del acido nodulisporico.
DK316188A (da) Sulfolipopolysaccharider som stimolatorer for den ikke specifikke forsvarsmekanisme
NO884921D0 (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.
RU93004862A (ru) Полипептидные соединения, обладающие способностью выделять гормон роста
NO882234D0 (no) Fremgangsmaate for fremstilling av oeredraapepreparat.
FI95779C (fi) Desinfiointikoostumus stafylokokkien tappamiseksi
SU1432991A1 (ru) 4-Метил-5-(4-метилфениламино)-1,2,3-триазол, обладающий противовоспалительной активностью

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 540676

Country of ref document: ES